000			02249 a2200577 4500
005			20250516164624.0
264		0	_c20140415
008			201404s 0 0 eng d
022			_a1573-7217
024	7		_a10.1007/s10549-013-2667-y _2doi
040			_aNLM _beng _cNLM
100	1		_aCatania, Angela
245	0	0	_aImmunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells. _h[electronic resource]
260			_bBreast cancer research and treatment _cAug 2013
300			_a55-65 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntibodies, Monoclonal, Humanized _xadministration & dosage
650	0	4	_aAnticarcinogenic Agents _xadministration & dosage
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aBiological Availability
650	0	4	_aBiological Products _xadministration & dosage
650	0	4	_aBreast Neoplasms _xmetabolism
650	0	4	_aCarcinoma, Ductal, Breast _xmetabolism
650	0	4	_aCell Division _xdrug effects
650	0	4	_aCell Line, Tumor _xdrug effects
650	0	4	_aCholesterol
650	0	4	_aChromatography, High Pressure Liquid
650	0	4	_aCurcumin _xadministration & dosage
650	0	4	_aDrug Compounding
650	0	4	_aDrug Screening Assays, Antitumor
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aGenes, erbB-2
650	0	4	_aHumans
650	0	4	_aImmunoconjugates _xadministration & dosage
650	0	4	_aLiposomes
650	0	4	_aNeoplasm Proteins _xbiosynthesis
650	0	4	_aParticle Size
650	0	4	_aPhosphatidylcholines
650	0	4	_aPhosphatidylethanolamines
650	0	4	_aReceptor, ErbB-2 _xbiosynthesis
650	0	4	_aResveratrol
650	0	4	_aStilbenes _xadministration & dosage
650	0	4	_aTrastuzumab
700	1		_aBarrajón-Catalán, Enrique
700	1		_aNicolosi, Silvia
700	1		_aCicirata, Federico
700	1		_aMicol, Vicente
773	0		_tBreast cancer research and treatment _gvol. 141 _gno. 1 _gp. 55-65
856	4	0	_uhttps://doi.org/10.1007/s10549-013-2667-y _zAvailable from publisher's website
999			_c23017311 _d23017311